NCT04774627View on ClinicalTrials.gov

Pancytopenia Related to PARP Inhibitors (PancytoRIB)

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

February 7, 2021

Primary Completion Date

February 27, 2021

Study Completion Date

March 24, 2021

Conditions
Cancer
Interventions
DRUG

PARP inhibitor

All patients treated at least with 1 PARPi

Trial Locations (1)

14000

Alexandre Joachim, Caen

All Listed Sponsors
lead

University Hospital, Caen

OTHER

NCT04774627 - Pancytopenia Related to PARP Inhibitors (PancytoRIB) | Biotech Hunter | Biotech Hunter